相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High VISTA Expression Correlates With a Favorable Prognosis in Patients With Colorectal Cancer
Liju Zong et al.
JOURNAL OF IMMUNOTHERAPY (2021)
Infiltrating Immune Cells in Gastric Cancer: A Novel Predicting Model for Prognosis
Wenjie Li et al.
JOURNAL OF CANCER (2021)
VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer
Liju Zong et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Promising approaches in cancer immunotherapy
Nima Taefehshokr et al.
IMMUNOBIOLOGY (2020)
VISTA: Coming of age as a multi-lineage immune checkpoint
M. A. ElTanbouly et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Structural insight into T cell coinhibition by PD-1H (VISTA)
Benjamin T. Slater et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
VISTA is a checkpoint regulator for naive T cell quiescence and peripheral tolerance
Mohamed A. ElTanbouly et al.
SCIENCE (2020)
Prognostic value of VISTA in solid tumours: a systematic review and meta-analysis
Xin-Lin He et al.
SCIENTIFIC REPORTS (2020)
FOXD3 Regulates VISTA Expression in Melanoma
Sheera R. Rosenbaum et al.
CELL REPORTS (2020)
Expression of the immune checkpoint VISTA in breast cancer
Liju Zong et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Comprehensive landscape of immune-checkpoints uncovered in clear cell renal cell carcinoma reveals new and emerging therapeutic targets
Diana Tronik-Le Roux et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer
Reem Saleh et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer
Mara Kitsou et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy
Xing Huang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Immune checkpoints in tumor microenvironment and their relevance to the development of cancer stem cells
Neda Khosravi et al.
LIFE SCIENCES (2020)
An engineered antibody binds a distinct epitope and is a potent inhibitor of murine and human VISTA
Nishant Mehta et al.
SCIENTIFIC REPORTS (2020)
The prognostic significance of VISTA and CD33-positive myeloid cells in cutaneous melanoma and their relationship with PD-1 expression
Jae Won Choi et al.
SCIENTIFIC REPORTS (2020)
VISTA Re-programs Macrophage Biology Through the Combined Regulation of Tolerance and Anti-inflammatory Pathways
Mohamed A. ElTanbouly et al.
FRONTIERS IN IMMUNOLOGY (2020)
VISTA/PSGL1 axis as a dominant immunomodulatory pathway in human non-small cell lung cancer
Alicia Ding et al.
CANCER RESEARCH (2020)
The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer
Xiaoxue Xie et al.
FRONTIERS IN IMMUNOLOGY (2020)
Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?
Negar Hosseinkhani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade
Karsten A. Pilones et al.
ONCOIMMUNOLOGY (2020)
VSIG-3 as a ligand of VISTA inhibits human T-cell function
Jinghua Wang et al.
IMMUNOLOGY (2019)
Immunotherapy in colorectal cancer: rationale, challenges and potential
Karuna Ganesh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
The expression of the immune checkpoint regulator VISTA correlates with improved overall survival in pT1/2 tumor stages in esophageal adenocarcinoma
Heike Loeser et al.
ONCOIMMUNOLOGY (2019)
PD-L1, B7-H3 and VISTA are highly expressed in gestational trophoblastic neoplasia
Liju Zong et al.
HISTOPATHOLOGY (2019)
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Anand Rotte
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Analysis of VISTA expression and function in renal cell carcinoma highlights VISTA as a potential target for immunotherapy
Shanjuan Hong et al.
PROTEIN & CELL (2019)
Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell-Mediated Inflammation and Immunosuppression
Wenwen Xu et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study
Antonella Argentiero et al.
CANCERS (2019)
Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer
Apostolos Zaravinos et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Structure and Functional Binding Epitope of V-domain Ig Suppressor of T Cell Activation
Nishant Mehta et al.
CELL REPORTS (2019)
VISTA is an acidic pH-selective ligand for PSGL-1
Robert J. Johnston et al.
NATURE (2019)
VISTA expressed in tumour cells regulates T cell function
Kumuluzi Mulati et al.
BRITISH JOURNAL OF CANCER (2019)
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer
Jorge Blando et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma
Ming Zhang et al.
BMC CANCER (2018)
VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival
Lawrence F. Kuklinski et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
High-Density Infiltration of V-domain Immunoglobulin Suppressor of T-cell Activation Up-regulated Immune Cells in Human Pancreatic Cancer
Jin'e Liu et al.
PANCREAS (2018)
Immune cell landscape in therapy-naive squamous cell and adenocarcinomas of the lung
Luka Brcic et al.
VIRCHOWS ARCHIV (2018)
Expression of V-domain immunoglobulin suppressor of T cell activation is associated with the advanced stage and presence of lymph node metastasis in ovarian cancer
Hong Liao et al.
ONCOLOGY LETTERS (2018)
VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML
Liru Wang et al.
ONCOIMMUNOLOGY (2018)
Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors
Shan Xie et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma
Claudia Capparelli et al.
CANCER RESEARCH (2018)
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
Ming Yi et al.
MOLECULAR CANCER (2018)
VISTA expression by microglia decreases during inflammation and is differentially regulated in CNS diseases
Malte Borggrewe et al.
GLIA (2018)
A crucial role of the PD-1H coinhibitory receptor in suppressing experimental asthma
Huafeng Liu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non-Small Cell Lung Cancer
Franz Villarroel-Espindola et al.
CLINICAL CANCER RESEARCH (2018)
Immunoregulatory functions of VISTA
Elizabeth C. Nowak et al.
IMMUNOLOGICAL REVIEWS (2017)
Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients
Hojabr Kakavand et al.
MODERN PATHOLOGY (2017)
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
Jianjun Gao et al.
NATURE MEDICINE (2017)
The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?
Christine Boeger et al.
ONCOIMMUNOLOGY (2017)
Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis
Na Li et al.
SCIENTIFIC REPORTS (2017)
Leukocyte trafficking in tumor microenvironment
Annalisa Del Prete et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes
Sabrina Ceeraz et al.
ARTHRITIS RESEARCH & THERAPY (2017)
HMBD002, a novel neutralizing antibody targeting a specific epitope on the co-inhibitory immune checkpoint receptor VISTA, displays potent anti-tumor effects in pre-clinical models
Piers J. Ingram et al.
CANCER RESEARCH (2017)
Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma
Lei Wu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
FOXD3 Regulates Pluripotent Stem Cell Potential by Simultaneously Initiating and Repressing Enhancer Activity
Raga Krishnakumar et al.
CELL STEM CELL (2016)
Impact of the physical microenvironment on tumor progression and metastasis
Fabian Spill et al.
CURRENT OPINION IN BIOTECHNOLOGY (2016)
Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma
Yuta Kondo et al.
ORAL ONCOLOGY (2016)
A New VISTA on combination therapy for negative checkpoint regulator blockade
Jie Deng et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation
Patricia Oliveira et al.
SCIENTIFIC REPORTS (2016)
Enhanced VISTA Expression in a Subset of Patients with Acute Myeloid Leukemia
Adam Lamble et al.
BLOOD (2016)
Fibroblast-derived Neuregulin 1 Promotes Compensatory ErbB3 Receptor Signaling in Mutant BRAF Melanoma
Claudia Capparelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses
Jun Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Expression of the Novel Costimulatory Molecule B7-H5 in Pancreatic Cancer
Joshua T. Byers et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
VISTA Is an Immune Checkpoint Molecule for Human T Cells
J. Louise Lines et al.
CANCER RESEARCH (2014)
VISTA Regulates the Development of Protective Antitumor Immunity
Isabelle Le Mercier et al.
CANCER RESEARCH (2014)
Coinhibitory receptor PD-1H preferentially suppresses CD4+ T cell-mediated immunity
Dallas B. Flies et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Characterization of Programmed Death-1 Homologue-1 (PD-1H) Expression and Function in Normal and HIV Infected Individuals
Preeti Bharaj et al.
PLOS ONE (2014)
Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity
Li Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
miR-125b Regulates the Early Steps of ESC Differentiation through Dies1 in a TGF-Independent Manner
Marica Battista et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
The Immunoglobulin Superfamily Protein Differentiation of Embryonic Stem Cells 1 (Dies1) Has a Regulatory Role in Preadipocyte to Adipocyte Conversion
Gang Ren et al.
PLOS ONE (2013)
A regulatory loop involving Dies1 and miR-125a controls BMP4 signaling in mouse embryonic stem cells
Silvia Parisi et al.
FASEB JOURNAL (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Cancer Immunotherapy Comes of Age
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
Li Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Cutting Edge: A Monoclonal Antibody Specific for the Programmed Death-1 Homolog Prevents Graft-versus-Host Disease in Mouse Models
Dallas B. Flies et al.
JOURNAL OF IMMUNOLOGY (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
分享论文
